Table 3.
Growth parameters, laboratory data, and irritable bowel syndrome scores in all patients at the start versus at the end of the study
|
Variables
|
Group I (Mediterranean diet) (n = 50)
|
Group II (n = 50)
|
P
value
1
|
|||||
|
Start
|
End
|
P
value
|
Start
|
End
|
P
value
|
|||
| Growthparameters | Height (z-score) | 0.04 ± 1 | 0.04 ± 0.92 | 0.88 | 0.04 ± 1.00 | 0.04 ± 0.99 | 0.63 | 0.18 |
| Weight (z-score) | 0.14 ± 0.99 | 0.13 ± 1.0 | 0.54 | 0.12 ± 0.89 | 0.12 ± 0.55 | 0.61 | 0.36 | |
| BMI (z-score) | 0.18 ± 0.88 | 0.17 ± 0.69 | 0.6 | 0.17 ± 1.02 | 0.16 ± 1.08 | 0.80 | 0.55 | |
| Laboratory data | Albumin (g/dL) | 4.10 ± 0.90 | 4.3 ± 0.94 | 0.77 | 4.30 ± 0.88 | 4.50 ± 0.91 | 0.49 | 0.54 |
| Triglycerides (mg/dL) | 120.7 0 ± 45.60 | 118.50 ± 47.10 | 0.90 | 112.90 ± 49.40 | 115.20 ± 50.40 | 0.51 | 0.65 | |
| Cholesterol (mg/dL) | 154 ± 36.60 | 155.80 ± 32.20 | 0.56 | 163.60 ± 44.1 | 168.10 ± 42.90 | 0.63 | 0.28 | |
| Glucose (mg/dL) | 86.2 ± 20.20 | 81.90 ± 24.50 | 0.27 | 85.7 ± 9.7 | 87.30 ± 11.20 | 0.28 | 0.73 | |
| Hemoglobin (g/dL) | 13.1 ± 1.60 | 14.00 ± 1.10 | 0.66 | 13.60 ± 1.80 | 13.20 ± 1.50 | 0.71 | 0.33 | |
| Fecal calprotectin (μg/g) n < 50 | 12 ± 9.10 | 11.30 ± 9.90 | 0.81 | 11 ± 8.80 | 10.80 ± 9.20 | 0.88 | 0.62 | |
| IBS scores | IBS-SSS | 237.20 ± 65 | 163.20 ± 33.80 | 0.0011 | 248.3 ± 71.1 | 228.50 ± 54.30 | 0.29 | < 0.0011 |
| IBS-QoL | 57.30 ± 12.9 | 72.40 ± 11.2 | <0.0011 | 59.1 ± 11.7 | 59.20 ± 12.70 | 0.77 | < 0.0011 | |
| Total score | 24.10 ± 10.4 | 28.80 ± 11.20 | 0.021 | 22.8 ± 13.50 | 22.10 ± 12.50 | 0.94 | 0.031 | |
1
P value is for group I vs group II at the end of the study.
BMI: Body mass index; IBS: Irritable bowel syndrome; IBS-SSS: IBS symptoms severity score questionnaire; IBS-QoL: IBS quality of life questionnaire.